|
1
|
Kang SG, Shinojima N, Hossain A, Gumin J,
Yong RL, Colman H, Marini F, Andreeff M and Lang FF: Isolation and
perivascular localization of mesenchymal stem cells from mouse
brain. Neurosurgery. 67:711–720. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Park D, Spencer JA, Koh BI, Kobayashi T,
Fujisaki J, Clemens TL, Lin CP, Kronenberg HM and Scadden DT:
Endogenous bone marrow MSCs are dynamic, fate-restricted
participants in bone maintenance and regeneration. Cell Stem Cell.
10:259–272. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Crisan M, Yap S, Casteilla L, Chen CW,
Corselli M, Park TS, Andriolo G, Sun B, Zheng B, Zhang L, Norotte
C, Teng PN, Traas J, Schugar R, Deasy BM, Badylak S, Buhring HJ,
Giacobino JP, Lazzari L, Huard J and Péault B: A perivascular
origin for mesenchymal stem cells in multiple human organs. Cell
Stem Cell. 3:301–313. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Pittenger M, Mackay A, Beck S, Jaiswal R,
Douglas R, Mosca J, Moorman M, Simonetti D, Craig S and Marshak D:
Multilineage potential of adult human mesenchymal stem cells.
Science. 284:143–147. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Sotiropoulou PA, Perez SA, Gritzapis AD,
Baxevanis CN and Papamichail M: Interactions between human
mesenchymal stem cells and natural killer cells. Stem Cells.
24:74–85. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Li H, Guo Z, Jiang X, Zhu H, Li X and Mao
N: Mesenchymal stem cells alter migratory property of T and
dendritic cells to delay the development of murine lethal acute
graft-versus-host disease. Stem Cells. 26:2531–2541. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Ho IA, Chan KY, Ng WH, Guo CM, Hui KM,
Cheang P and Lam PY: Matrix metalloproteinase 1 is necessary for
the migration of human bone marrow-derived mesenchymal stem cells
toward human glioma. Stem Cells. 27:1366–1375. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Nakamura K, Ito Y, Kawano Y, Kurozumi K,
Kobune M, Tsuda H, Bizen A, Honmou O, Niitsu Y and Hamada H:
Antitumor effect of genetically engineered mesenchymal stem cells
in a rat glioma model. Gene Ther. 11:1155–1164. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Bexell D, Gunnarsson S, Tormin A, Darabi
A, Gisselsson D, Roybon L, Scheding S and Bengzon J: Bone marrow
multipotent mesenchymal stroma cells act as pericyte-like migratory
vehicles in experimental gliomas. Mol Ther. 17:183–190. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Nakamizo A, Marini F, Amano T, Khan A,
Studeny M, Gumin J, Chen J, Hentschel S, Vecil G, Dembinski J,
Andreeff M and Lang FF: Human bone marrow-derived mesenchymal stem
cells in the treatment of gliomas. Cancer Res. 65:3307–3318.
2005.PubMed/NCBI
|
|
11
|
Yang B, Wu X, Mao Y, Bao W, Gao L, Zhou P,
Xie R, Zhou L and Zhu J: Dual-targeted antitumor effects against
brainstem glioma by intravenous delivery of tumor necrosis
factor-elated, apoptosis-inducing, ligand-engineered human
mesenchymal stem cells. Neurosurgery. 65:610–624. 2009. View Article : Google Scholar
|
|
12
|
Uchibori R, Okada T, Ito T, Urabe M,
Mizukami H, Kume A and Ozawa K: Retroviral vector producing
mesenchymal stem cells for targeted suicide cancer gene therapy. J
Gene Med. 11:373–381. 2009. View
Article : Google Scholar : PubMed/NCBI
|
|
13
|
Matuskova M, Hlubinova K, Pastorakova A,
Hunakova L, Altanerova V, Altaner C and Kucerova L: HSV-tk
expressing mesenchymal stem cells exert bystander effect on human
glioblastoma cells. Cancer Lett. 290:58–67. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Guo P, Hu B, Gu W, Xu L, Wang D, Huang
HJS, Cavenee WK and Cheng SY: Platelet-derived growth factor-B
enhances glioma angiogenesis by stimulating vascular endothelial
growth factor expression in tumor endothelia and by promoting
pericyte recruitment. Am J Pathol. 162:1083–1093. 2003. View Article : Google Scholar
|
|
15
|
Heldin CH and Westermark B: Mechanism of
action and in vivo role of platelet-derived growth factor. Physiol
Rev. 79:1283–1316. 1999.PubMed/NCBI
|
|
16
|
Cheng P, Gao ZQ, Liu YH and Xue YX:
Platelet-derived growth factor BB promotes the migration of bone
marrow-derived mesenchymal stem cells towards C6 glioma and
up-regulates the expression of intracellular adhesion molecule-1.
Neurosci Lett. 451:52–56. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Hata N, Shinojima N, Gumin J, Yong R,
Marini F, Andreeff M and Lang FF: Platelet-derived growth factor BB
mediates the tropism of human mesenchymal stem cells for malignant
gliomas. Neurosurgery. 66:144–156. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Engelhardt B: Molecular mechanisms
involved in T cell migration across the blood-brain barrier. J
Neural Transm. 113:477–485. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Mestre L, Iñigo PM, Mecha M, Correa FG,
Hernangómez-Herrero M, Loría F, Docagne F, Borrell J and Guaza C:
Anandamide inhibits Theiler’s virus induced VCAM-1 in brain
endothelial cells and reduces leukocyte transmigration in a model
of blood brain barrier by activation of CB(1) receptors. J
Neuroinflammation. 8:102 View Article : Google Scholar : 2011.
|
|
20
|
Hu Y, Cheng P, Xue YX and Liu YH: Glioma
cells promote the expression of vascular cell adhesion molecule-1
on bone marrow-derived mesenchymal stem cells: a possible mechanism
for their tropism toward gliomas. J Mol Neurosci. 48:127–135. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Segers VFM, Van Riet I, Andries LJ,
Lemmens K, Demolder MJ, De Becker AJML, Kockx MM and De Keulenaer
GW: Mesenchymal stem cell adhesion to cardiac microvascular
endothelium: activators and mechanisms. American journal of
physiology Am J Physiol Heart Circ Physiol. 290:H1370–H1377. 2006.
View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Seo J, Lee HS, Ryoo S, Seo JH, Min BS and
Lee JH: Tangeretin, a citrus flavonoid, inhibits PGDF-BB-induced
proliferation and migration of aortic smooth muscle cells by
blocking AKT activation. Eur J Pharmacol. 673:56–64. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Chen HF, Xie LD and Xu CS: The signal
transduction pathways of heat shock protein 27 phosphorylation in
vascular smooth muscle cells. Mol Cell Biochem. 333:49–56. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Yoshimura H, Nariai Y, Terashima M, Mitani
T and Tanigawa Y: Taurine suppresses platelet-derived growth factor
(PDGF) BB-induced PDGF-β receptor phosphorylation by protein
tyrosine phosphatase-mediated dephosphorylation in vascular smooth
muscle cells. Biochim Biophys Acta. 1745:350–360. 2005.PubMed/NCBI
|
|
25
|
Zheng L, Ishii Y, Tokunaga A, Hamashima T,
Shen J, Zhao QL, Ishizawa S, Fujimori T, Nabeshima YI, Mori H,
Kondo T and Sasahara M: Neuroprotective effects of PDGF against
oxidative stress and the signaling pathway involved. J Neurosci
Res. 88:1273–1284. 2010.PubMed/NCBI
|
|
26
|
Romashkova JA and Makarov SS: NF-kappaB is
a target of AKT in anti-apoptotic PDGF signalling. Nature.
401:86–90. 1999. View
Article : Google Scholar : PubMed/NCBI
|
|
27
|
Birnbaum T, Roider J, Schankin CJ, Padovan
CS, Schichor C, Goldbrunner R and Straube A: Malignant gliomas
actively recruit bone marrow stromal cells by secreting angiogenic
cytokines. J Neurooncol. 83:241–247. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Jiang B, Xu S, Hou X, Pimentel DR and
Cohen RA: Angiotensin II differentially regulates
interleukin-1-β-inducible NO synthase (iNOS) and vascular cell
adhesion molecule-1 (VCAM-1) expression: role of p38 MAPK. J Biol
Chem. 279:20363–20368. 2004.PubMed/NCBI
|
|
29
|
Xiao Q, Wang S, Tian H, Xin L, Zou Z, Hu
Y, Chang C, Wang X, Yin Q, Zhang X and Wang L: TNF-α increases bone
marrow mesenchymal stem cell migration to ischemic tissues. Cell
Biochem Biophys. 62:409–414. 2012.
|
|
30
|
Harting M, Jimenez F, Pati S, Baumgartner
J and Cox C: Immunophenotype characterization of rat mesenchymal
stromal cells. Cytotherapy. 10:243–253. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Westermark B, Heldin C-H and Nistér M:
Platelet-derived growth factor in human glioma. Glia. 15:257–263.
1995. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Maher EA, Furnari FB, Bachoo RM, Rowitch
DH, Louis DN, Cavenee WK and DePinho RA: Malignant glioma: genetics
and biology of a grave matter. Genes Dev. 15:1311–1333. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Yilmaz G and Granger DN: Leukocyte
recruitment and ischemic brain injury. Neuromolecular Med.
12:193–204. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Wang X, Feuerstein GZ, Gu JL, Lysko PG and
Yue TL: Interleukin-1β induces expression of adhesion molecules in
human vascular smooth muscle cells and enhances adhesion of
leukocytes to smooth muscle cells. Atherosclerosis. 115:89–98.
1995.
|
|
35
|
Menon LG, Picinich S, Koneru R, Ggo H, Lin
SY, Koneru M, Mayer-Kuchku P and Glod J: Differential gene
expression associated with migration of mesenchymal stem cells to
conditioned medium from tumor cells or bone marrow cells. Stem
Cells. 25:520–528. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Ryu CH, Park SH, Park SA, Kim SM, Lim JY,
Jeong CH, Yoon WS, Oh W, Sung YC and Jeun SS: Gene therapy of
intracranial glioma using interleukin 12-secreting human umbilical
cord blood-derived mesenchymal stem cells. Hum Gene Ther.
22:733–743. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Spaeth E, Klopp A, Dembinski J, Andreeff M
and Marini F: Inflammation and tumor microenvironments: defining
the migratory itinerary of mesenchymal stem cells. Gene Ther.
15:730–738. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Schichor C, Birnbaum T, Etminan N, Schnell
O, Grau S, Miebach S, Aboody K, Padovan C, Straube A, Tonn JC and
Goldbrunner R: Vascular endothelial growth factor A contributes to
glioma-induced migration of human marrow stromal cells (hMSC). Exp
Neurol. 199:301–310. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Ponte ALL, Marais E, Gallay N, Langonne A,
Delorme B, Herault O, Charbord P, Domenech J, Langonné A and
Hérault O: The in vitro migration capacity of human bone marrow
mesenchymal stem cells: comparison of chemokine and growth factor
chemotactic activities. Stem Cells. 25:1737–1745. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Nazarenko I, Hede S-M, He X, Hedrén A,
Thompson J, Lindström MS and Nistér M: PDGF and PDGF receptors in
glioma. Ups J Med Sci. 117:99–112. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Jiang Y, Boije M, Westermark B and Uhrbom
L: PDGF-B can sustain self-renewal and tumorigenicity of
experimental glioma-derived cancer-initiating cells by preventing
oligodendrocyte differentiation. Neoplasia. 13:492–503. 2011.
|
|
42
|
Tondreau T, Meuleman N, Stamatopoulos B,
De Bruyn C, Delforge A, Dejeneffe M, Martiat P, Bron D and Lagneaux
L: In vitro study of matrix metalloproteinase/tissue inhibitor of
metalloproteinase production by mesenchymal stromal cells in
response to inflammatory cytokines: the role of their migration in
injured tissues. Cytotherapy. 11:559–569. 2009. View Article : Google Scholar
|
|
43
|
Hyun YM, Chung HL, McGrath JL, Waugh RE
and Kim M: Activated integrin VLA-4 localizes to the lamellipodia
and mediates T cell migration on VCAM-1. J Immunol. 183:359–369.
2009. View Article : Google Scholar : PubMed/NCBI
|
